This is the season for a rise in RSV cases. We talk to a local doctor on how to treat and stop the spread. Stay up-to-date: The latest headlines and weather from WPBF 25Click here to learn more.

NHS England has appealed for 1.3 million eligible people to come forward for a new jab against respiratory syncytial virus (RSV) which can lead to serious complications in some. It is sending ...

NHS England announced on Monday that more than one million adults in England, aged between 75 and 79, or those who turned 80 after September 1, will be invited to receive the RSV jab over the next ...

More than one million Brits are being urged to get a potentially "life-saving" new jab against respiratory syncytial virus (RSV). NHS officials have urgently invited elderly people in England to ...

Invites are being sent this week to people not yet vaccinated against RSV who are aged 75-79 or turned 80 after 1 September 2024, encouraging them to book an appointment with their GP. RSV spreads all ...

The patents in contention are numbers 3,109,258, 2,222,710 and 3,178,490, all awarded by the European Patent Office and covering recombinant RSV antigens and compositions and methods for making them.

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...